Early signs indicate coronavirus vaccine is effective
An interim analysis of study data from a coronavirus vaccine being developed by Pfizer and BioNTech indicates that the vaccine is highly effective in preventing COVID-19. Researchers and volunteers in Rochester have been involved in the testing of the vaccine since May, when the first human studies were launched, and technologies used in the development of the vaccine can trace their origins to decades of infectious disease research conducted at the University of Rochester Medical Center.
First worldwide trial tests defibrillators in diabetes patients
Individuals with diabetes have a high incidence of heart problems. A Medical Center study will determine if implantable defibrillators increase survival in this growing group of patients.
Medical Center plays key role in new Huntington’s drug
Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.
Skin sensors provide wealth of patient data
In one current clinical trial, biosensors worn by patients with Parkinson’s and Huntington’s disease generate 25 million measurements over a two-day period.